Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
Merck (MRK.N), whose Recombivax HB has been a staple of the U.S. childhood immunization program, said it was "deeply concerned" by the decision of the CDC's Advisory Committee on Immunization Practice...